# Quin

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/quin-b-v

- Industry: Healthcare
- Headquarters: Amsterdam, Netherlands
- Website: www.quin.md
- Total disclosed funding: $30M
- Latest round: Series A (Jan 18, 2021)
- Investors on record: 3

## About

Based in the Netherlands, Quin B.V. is a healthcare technology company that develops innovative digital solutions for general practitioners and specialized healthcare providers, enhancing patient access and operational efficiency.Quin B.V. focuses on providing digital healthcare solutions. The company was founded by Bart Malenstein, Jami Curl, and Joaquín Durand, with Bart Malenstein serving as the CEO. Headquartered in Amsterdam, Netherlands, Quin has secured a total of EUR 25 million in funding, with the most recent deal being a Series A round on January 18, 2021, led by Partners in Equity alongside investors Bergman Clinics B.V. and ExO Capital.Quin specializes in developing user-friendly digital solutions tailored for general practitioners and specialized healthcare providers. Their primary offerings include a digital triage tool named ZorgvraagHulp, which acts as a digital gateway for patients to access healthcare services. This tool helps manage patient inquiries efficiently, enabling practitioners to address more than 30% of incoming care questions automatically. Additionally, Quin incorporates an AI-driven symptom checker that assists patients in evaluating their symptoms, streamlining the communication and triage process between healthcare providers and patients. The company’s client base mainly consists of general practitioners, healthcare organizations, and hospitals across European markets, focusing on improving patient access to care and enhancing workflow efficiency within medical practices.Quin generates revenue through a subscription-based model, where healthcare providers pay for access to their digital solutions such as ZorgvraagHulp and the symptom checker. These subscription plans include different tiers based on the size of the practice and the specific features utilized, allowing flexibility for clients that range from individual practitioners to larger hospital systems. Additionally, Quin may engage in partnerships with healthcare organizations, further diversifying their revenue streams. Transactions are structured to provide ongoing support and updates to the software, ensuring that clients receive the latest enhancements and maintain optimal operational efficiency. The firm’s innovative solutions not only facilitate improved patient care but also help healthcare providers save time and resources.Quin B.V. plans to utilize the EUR 25 million raised in Series A funding to expand internationally, with a focus on entering the German market. The company aims to enhance its app and platform by integrating data-driven care pathways, making these innovations accessible to more general practitioner practices. This expansion is part of Quin's strategic initiative to broaden its reach and improve healthcare delivery by 2023.

## Funding rounds

- Series A, Jan 18, 2021, $30M — Bergman Clinics B.V., Partners in Equity, ExO Capital

## Investors

- Bergman Clinics B.V. — Series A
- Partners in Equity (https://capitalatlas.ai/funds/partners-in-equity) — Series A
- ExO Capital — Series A